In MLL-FP models, KDM1A is required for leukemic stem cell function, whereas in other AML-subtype cell line models, its inhibition prevents tumor growth by inhibiting cancer cell proliferation, differentiation, invasion, and migration [62,63]. Here, KMT2A is linked to acute myeloid leukemia.